Trial intelligence / Profile preview

Preemptive Sphenopalatine Ganglion Block in FESS

NCT00927888Phase 4Completed

Sponsor
Stanford University
Start
Aug 2007
Primary completion
Mar 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of bupivacaine in postoperative pain, sponsored by Stanford University. Started Aug 2007; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT00927888.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00927888.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call